| Product Code: ETC12651909 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Leishmaniasis Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Leishmaniasis Market Revenues & Volume, 2021 & 2031F |
3.3 China Leishmaniasis Market - Industry Life Cycle |
3.4 China Leishmaniasis Market - Porter's Five Forces |
3.5 China Leishmaniasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 China Leishmaniasis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.7 China Leishmaniasis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 China Leishmaniasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 China Leishmaniasis Market Revenues & Volume Share, By Research Focus, 2021 & 2031F |
4 China Leishmaniasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of leishmaniasis cases in China |
4.2.2 Rising public health awareness about leishmaniasis |
4.2.3 Government initiatives to control and prevent leishmaniasis |
4.3 Market Restraints |
4.3.1 Lack of access to proper healthcare facilities in rural areas |
4.3.2 Limited availability and affordability of treatment options |
4.3.3 Insufficient funding for research and development of leishmaniasis treatments |
5 China Leishmaniasis Market Trends |
6 China Leishmaniasis Market, By Types |
6.1 China Leishmaniasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 China Leishmaniasis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 China Leishmaniasis Market Revenues & Volume, By Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.4 China Leishmaniasis Market Revenues & Volume, By Visceral Leishmaniasis, 2021 - 2031F |
6.1.5 China Leishmaniasis Market Revenues & Volume, By Mucocutaneous Leishmaniasis, 2021 - 2031F |
6.1.6 China Leishmaniasis Market Revenues & Volume, By Diffuse Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.7 China Leishmaniasis Market Revenues & Volume, By Post-Kala-Azar Dermal Leishmaniasis, 2021 - 2031F |
6.2 China Leishmaniasis Market, By Diagnosis Method |
6.2.1 Overview and Analysis |
6.2.2 China Leishmaniasis Market Revenues & Volume, By Microscopic Examination, 2021 - 2031F |
6.2.3 China Leishmaniasis Market Revenues & Volume, By Serological Tests, 2021 - 2031F |
6.2.4 China Leishmaniasis Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.2.5 China Leishmaniasis Market Revenues & Volume, By Culture Methods, 2021 - 2031F |
6.2.6 China Leishmaniasis Market Revenues & Volume, By Montenegro Skin Test, 2021 - 2031F |
6.3 China Leishmaniasis Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 China Leishmaniasis Market Revenues & Volume, By Antimonial Compounds, 2021 - 2031F |
6.3.3 China Leishmaniasis Market Revenues & Volume, By Amphotericin B, 2021 - 2031F |
6.3.4 China Leishmaniasis Market Revenues & Volume, By Miltefosine, 2021 - 2031F |
6.3.5 China Leishmaniasis Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.3.6 China Leishmaniasis Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4 China Leishmaniasis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Leishmaniasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Leishmaniasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 China Leishmaniasis Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 China Leishmaniasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4.6 China Leishmaniasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5 China Leishmaniasis Market, By Research Focus |
6.5.1 Overview and Analysis |
6.5.2 China Leishmaniasis Market Revenues & Volume, By Parasite Biology, 2021 - 2031F |
6.5.3 China Leishmaniasis Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.5.4 China Leishmaniasis Market Revenues & Volume, By Drug Resistance Mechanisms, 2021 - 2031F |
6.5.5 China Leishmaniasis Market Revenues & Volume, By Vector Control Strategies, 2021 - 2031F |
6.5.6 China Leishmaniasis Market Revenues & Volume, By Epidemiological Studies, 2021 - 2031F |
7 China Leishmaniasis Market Import-Export Trade Statistics |
7.1 China Leishmaniasis Market Export to Major Countries |
7.2 China Leishmaniasis Market Imports from Major Countries |
8 China Leishmaniasis Market Key Performance Indicators |
8.1 Number of reported leishmaniasis cases in China |
8.2 Adoption rate of preventive measures against leishmaniasis |
8.3 Investment in research and development for leishmaniasis treatments |
9 China Leishmaniasis Market - Opportunity Assessment |
9.1 China Leishmaniasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 China Leishmaniasis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.3 China Leishmaniasis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 China Leishmaniasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 China Leishmaniasis Market Opportunity Assessment, By Research Focus, 2021 & 2031F |
10 China Leishmaniasis Market - Competitive Landscape |
10.1 China Leishmaniasis Market Revenue Share, By Companies, 2024 |
10.2 China Leishmaniasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here